AQP4 and optic neuritis: MOGAD has been described to manifest with various clinical manifestations including optic neuritis, acute myelitis, NMOSD-like phenotype without AQP4 antibodies, ADEM, MDEM, cortical encephalitis, and, extremely rare, tumefactive-like presentation of demyelination lesions.